527
Participants
Start Date
July 2, 2019
Primary Completion Date
April 22, 2022
Study Completion Date
April 22, 2022
GP2411
60 mg /mL subcutaneous injection every 6 months
EU-Prolia (EU-authorized Prolia®)
60 mg /mL subcutaneous injection every 6 months
Sandoz Investigational Site, Sofia
Sandoz Investigational Site, Sofia
Sandoz Investigational Site, Sofia
Sandoz Investigational Site, Sofia
Sandoz Investigational Site, Plovdiv
Sandoz Investigational Site, Plovdiv
Sandoz Investigational Site, Prague
Sandoz Investigational Site, Santiago de Compostela
Sandoz Investigational Site, Santiago de Compostela
Sandoz Investigational Site, Duncansville
Sandoz Investigational Site, Wyomissing
Sandoz Investigational Site, Madrid
Sandoz Investigational Site, Pilsen
Sandoz Investigational Site, Miami
Sandoz Investigational Site, Seville
Sandoz Investigational Site, Wichita
Sandoz Investigational Site, Carrollton
Sandoz Investigational Site, Peoria
Sandoz Investigational Site, Ostrava
Sandoz Investigational Site, Hradec Králové
Sandoz Investigational Site, Brno
Sandoz Investigational Site, Ostrava
Sandoz Investigational Site, Pardubice
Sandoz Investigational Site, Prague
Sandoz Investigational Site, Uherské Hradiště
Sandoz Investigational Site, Fujimi
Sandoz Investigational Site, Chuoh-ku
Sandoz Investigational Site, Hachiōji
Sandoz Investigational Site, Kiyose
Sandoz Investigational Site, Shinagawa
Sandoz Investigational Site, Krakow
Sandoz Investigational Site, Bialystok
Sandoz Investigational Site, Bialystok
Sandoz Investigational Site, Bydgoszcz
Sandoz Investigational Site, Lodz
Sandoz Investigational Site, Nadarzyn
Sandoz Investigational Site, Torun
Sandoz Investigational Site, Warsaw
Sandoz Investigational Site, Warsaw
Sandoz Investigational Site, Warsaw
Sandoz Investigational Site, Sabadell
Sandoz Investigational Site, Barcelona